|

Norethindrone Acetate-Ethinyl Estradiol Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Estrogen-progestin

Pipeline

Early 1: 1

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Hypopituitarism1
  • Pediatric Disease1
  • Oxytocin Deficiency1
  • Arginine Vasopressin Deficiency1
  • Diabetes1

Boston, Massachusetts1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.